emavusertib
curis
['mds', 'aml,(-streamline),(-seamless),(-kamloops)', 'ca-4948']
findings suggest that ca-4948, a novel oral inhibitor of irak4 and flt3, is a promising treatment for heavily pretreated #aml and high-risk #myelodysplasticsyndrome patients: #asco22 #hemonc #mds 
Reporting essential clinical news w/ independent analysis for cancer care professionals to optimize patient care & outcomes; oncology/hematology